Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
Metabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, an important goal for research is to identify new m...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/20/6/1265 |
id |
doaj-471a9a773194479ba629adb762284237 |
---|---|
record_format |
Article |
spelling |
doaj-471a9a773194479ba629adb7622842372020-11-24T21:15:56ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-03-01206126510.3390/ijms20061265ijms20061265Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal FluidIlaria Cicalini0Claudia Rossi1Damiana Pieragostino2Luca Agnifili3Leonardo Mastropasqua4Maria di Ioia5Giovanna De Luca6Marco Onofrj7Luca Federici8Piero Del Boccio9Department of Pharmacy, University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyAnalytical Biochemistry and Proteomics Laboratory, Centre on Aging Sciences and Translational Medicine (Ce.S.I-MeT), University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyAnalytical Biochemistry and Proteomics Laboratory, Centre on Aging Sciences and Translational Medicine (Ce.S.I-MeT), University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyOpthalmic Clinic, Department of Medicine and Aging Science, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyOpthalmic Clinic, Department of Medicine and Aging Science, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, ItalyUnit of Neurology Ss Annunziata Hospital, 66100 Chieti, ItalyUnit of Neurology Ss Annunziata Hospital, 66100 Chieti, ItalyUnit of Neurology Ss Annunziata Hospital, 66100 Chieti, ItalyAnalytical Biochemistry and Proteomics Laboratory, Centre on Aging Sciences and Translational Medicine (Ce.S.I-MeT), University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Pharmacy, University ‘‘G. d’Annunzio’’ of Chieti-Pescara, 66100 Chieti, ItalyMetabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, an important goal for research is to identify new molecules in more easily accessible biological fluids. A very interesting biofluid in MuS is represented by tears, considered as an intermediate fluid between the cerebrospinal fluid and serum. In this work, we developed a merged strategy for the analysis of lipids containing choline by Liquid Chromatography coupled to Tandem Mass Spectrometry (LC-MS/MS), as well as for the targeted analysis of free carnitine, acylcarnitines and aminoacids by direct infusion mass spectrometry. Samples for both metabolomics and lipidomics approaches were obtained in a single extraction procedure from tears of patients affected by MuS and healthy controls. Tear lipidomics showed 30 phospholipids significantly modulated and, notably, many sphingomyelins resulted lower in MuS. Moreover, the metabolomics approach carried out both on tears and serum highlighted the diagnostic potential of specific aminoacids and acylcarnitines. In conclusion, the metabolic profiling of tears appears to reflect the pathological conditions of the central nervous system, suggesting that the molecular repository of tears can be considered as a source of potential biomarkers for MuS.http://www.mdpi.com/1422-0067/20/6/1265metabolomicslipidomicstearsbiomarkersamino acidsacylcarnitinesmultiple sclerosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ilaria Cicalini Claudia Rossi Damiana Pieragostino Luca Agnifili Leonardo Mastropasqua Maria di Ioia Giovanna De Luca Marco Onofrj Luca Federici Piero Del Boccio |
spellingShingle |
Ilaria Cicalini Claudia Rossi Damiana Pieragostino Luca Agnifili Leonardo Mastropasqua Maria di Ioia Giovanna De Luca Marco Onofrj Luca Federici Piero Del Boccio Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid International Journal of Molecular Sciences metabolomics lipidomics tears biomarkers amino acids acylcarnitines multiple sclerosis |
author_facet |
Ilaria Cicalini Claudia Rossi Damiana Pieragostino Luca Agnifili Leonardo Mastropasqua Maria di Ioia Giovanna De Luca Marco Onofrj Luca Federici Piero Del Boccio |
author_sort |
Ilaria Cicalini |
title |
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid |
title_short |
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid |
title_full |
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid |
title_fullStr |
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid |
title_full_unstemmed |
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid |
title_sort |
integrated lipidomics and metabolomics analysis of tears in multiple sclerosis: an insight into diagnostic potential of lacrimal fluid |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2019-03-01 |
description |
Metabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, an important goal for research is to identify new molecules in more easily accessible biological fluids. A very interesting biofluid in MuS is represented by tears, considered as an intermediate fluid between the cerebrospinal fluid and serum. In this work, we developed a merged strategy for the analysis of lipids containing choline by Liquid Chromatography coupled to Tandem Mass Spectrometry (LC-MS/MS), as well as for the targeted analysis of free carnitine, acylcarnitines and aminoacids by direct infusion mass spectrometry. Samples for both metabolomics and lipidomics approaches were obtained in a single extraction procedure from tears of patients affected by MuS and healthy controls. Tear lipidomics showed 30 phospholipids significantly modulated and, notably, many sphingomyelins resulted lower in MuS. Moreover, the metabolomics approach carried out both on tears and serum highlighted the diagnostic potential of specific aminoacids and acylcarnitines. In conclusion, the metabolic profiling of tears appears to reflect the pathological conditions of the central nervous system, suggesting that the molecular repository of tears can be considered as a source of potential biomarkers for MuS. |
topic |
metabolomics lipidomics tears biomarkers amino acids acylcarnitines multiple sclerosis |
url |
http://www.mdpi.com/1422-0067/20/6/1265 |
work_keys_str_mv |
AT ilariacicalini integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT claudiarossi integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT damianapieragostino integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT lucaagnifili integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT leonardomastropasqua integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT mariadiioia integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT giovannadeluca integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT marcoonofrj integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT lucafederici integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid AT pierodelboccio integratedlipidomicsandmetabolomicsanalysisoftearsinmultiplesclerosisaninsightintodiagnosticpotentialoflacrimalfluid |
_version_ |
1716744100238065664 |